These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8093956)

  • 41. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty.
    Klein K; Yang J; Aisenberg J; Wright N; Kaplowitz P; Lahlou N; Linares J; Lundström E; Purcea D; Cassorla F
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1241-1248. PubMed ID: 26887034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a subcutaneous endometriosis rat model.
    Pereira FE; Almeida PR; Dias BH; Vasconcelos PR; Guimarães SB; Medeiros Fd
    Acta Cir Bras; 2015 Jan; 30(1):6-12. PubMed ID: 25627266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Analogs of gonadoliberin in the treatment of endometriosis and uterine myoma. Comparison of daily subcutaneous treatment and intramuscular depot therapy].
    Horský J; Cerný M; Dvorák P; Lepová B; Zizkovský V; Vondrácek J
    Cesk Gynekol; 1989 Aug; 54(7):486-95. PubMed ID: 2529980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
    Fawzy M; Mesbah Y
    Arch Gynecol Obstet; 2015 Dec; 292(6):1267-71. PubMed ID: 25990480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endometriosis-associated infertility: evaluation of preoperative use of danazol, gestrinone, and buserelin.
    Donnez J; Nisolle-Pochet M; Casanas-Roux F
    Int J Fertil; 1990; 35(5):297-301. PubMed ID: 1980666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical appreciation of LHRH analogue formulations.
    Lemay A
    Horm Res; 1989; 32 Suppl 1():93-101; discussion 102. PubMed ID: 2533161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The medical treatment of mild endometriosis.
    Cooke ID; Thomas EJ
    Acta Obstet Gynecol Scand Suppl; 1989; 150():27-30. PubMed ID: 2533449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ovarian suppression treatment prior to in-vitro fertilization and embryo transfer in Chinese women with stage III or IV endometriosis.
    Ma C; Qiao J; Liu P; Chen G
    Int J Gynaecol Obstet; 2008 Feb; 100(2):167-70. PubMed ID: 18029283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of gestrinone after surgery in treatment of endometriosis.
    Nieto A; Tacuri C; Serra M; Keller J; Cortés-Prieto J
    Gynecol Obstet Invest; 1997; 43(3):192-4. PubMed ID: 9127134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of GnRH agonists in the treatment of endometriomas with or without drainage.
    Batioglu S; Celikkanat H; Ugur M; Mollamahmutoglu L; Yesilyurt H; Kundakci M
    J Pak Med Assoc; 1996 Feb; 46(2):30-2. PubMed ID: 8683844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment with triptorelin in mentally disordered sex offenders: experience from a maximum-security hospital.
    Ho DK; Kottalgi G; Ross CC; Romero-Ulceray J; Das M
    J Clin Psychopharmacol; 2012 Oct; 32(5):739-40. PubMed ID: 22926625
    [No Abstract]   [Full Text] [Related]  

  • 52. Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.
    Bertelloni S; Mucaria C; Baroncelli GI; Peroni D
    Expert Rev Clin Pharmacol; 2018 Jul; 11(7):659-667. PubMed ID: 29957076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy and safety of a 19 nor-steroid in the treatment of endometriosis.
    Yang TS; Tsan SH; Chen CR; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):89-96. PubMed ID: 8915110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of triptorelin and an extended-interval dosing regimen in the treatment of patients with endometriosis and adenomyoma].
    Liu DY; Gu MJ; Shu JZ; Shi YX; Wang CY; Han ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):656-9. PubMed ID: 17199917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
    Carel JC; Blumberg J; Seymour C; Adamsbaum C; Lahlou N;
    Eur J Endocrinol; 2006 Jan; 154(1):119-24. PubMed ID: 16382000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.
    Zenaty D; Blumberg J; Liyanage N; Jacqz-Aigrain E; Lahlou N; Carel JC;
    Horm Res Paediatr; 2016; 86(3):188-195. PubMed ID: 27603324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of digestive occlusion on an endometriosis lesion after treatment by GnRH agonist].
    Vieille P; Masia F; Donici I; Laporte S; Mares P; de Tayrac R
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7):668-71. PubMed ID: 22771074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tibolone as a hormone replacement in women with endometriosis after bilateral oophorectomy.
    Roberts AL; Lashen H
    Int J Gynaecol Obstet; 2010 Nov; 111(2):183. PubMed ID: 20656290
    [No Abstract]   [Full Text] [Related]  

  • 59. [D-Trp-6 gonadotropin analog releasing hormone (Decapeptyl-Depot)-- the drug of choice in central idiopathic precocious puberty].
    Hníková O; Janecková M; Finková M
    Cesk Pediatr; 1994; 49(1):22-4. PubMed ID: 8124745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical effects of gestrinone for the treatment of pelvic endometriosis in infertile patients.
    Pruksananonda K; Suwajanakorn S; Boonkasemsanti W; Virutamasen P
    J Med Assoc Thai; 1999 Jan; 82(1):9-14. PubMed ID: 10087732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.